Lordick, Florian, Al-Batran, Salah-Eddin, Dietel, Manfred, Gaiser, Timo, Hofheinz, Ralf-Dieter, Kirchner, Thomas, Kreipe, Hans H., Lorenzen, Sylvie, Moehler, Markus, Quaas, Alexander, Roecken, Christoph, Rueschoff, Josef, Tannapfel, Andrea, Thuss-Patience, Peter and Baretton, Gustavo (2017). HER2 testing in gastric cancer: results of a German expert meeting. J. Cancer Res. Clin. Oncol., 143 (5). S. 835 - 842. NEW YORK: SPRINGER. ISSN 1432-1335

Full text not available from this repository.

Abstract

Valid HER2 testing is essential for optimal therapy of patients with HER2-positive gastric cancer and the correct use of first-line chemotherapy. While testing for HER2 status in breast cancer is routinely performed, this is not the case for HER2 testing in gastric cancer and it is usually only performed on clinician request. An interdisciplinary German expert group (pathologists and clinicians) took the challenges of HER2 testing in gastric cancer as an opportunity to address essential aspects and questions for the practical use of HER2 testing in this indication. The recommendations made in this manuscript reflect the consensus of all participants and reflect their opinions and long-term experience in this field.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Lordick, FlorianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Al-Batran, Salah-EddinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dietel, ManfredUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gaiser, TimoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hofheinz, Ralf-DieterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kirchner, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kreipe, Hans H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lorenzen, SylvieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moehler, MarkusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Quaas, AlexanderUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Roecken, ChristophUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rueschoff, JosefUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tannapfel, AndreaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thuss-Patience, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Baretton, GustavoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-233307
DOI: 10.1007/s00432-017-2374-x
Journal or Publication Title: J. Cancer Res. Clin. Oncol.
Volume: 143
Number: 5
Page Range: S. 835 - 842
Date: 2017
Publisher: SPRINGER
Place of Publication: NEW YORK
ISSN: 1432-1335
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
PROGNOSTIC-FACTOR; RECOMMENDATIONS; AMPLIFICATION; ASSOCIATION; CARCINOMAMultiple languages
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/23330

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item